W. P. Geus

Impact of Goal-Oriented and Model-Based Clinical Pharmacokinetic Dosing of Aminoglycosides on Clinical Outcome: A Cost-Effectiveness Analysis

Nicolette A. E. M. van Lent-Evers, Ron A. A. Mathôt, W. P. Geus et al. · Therapeutic Drug Monitoring · 1999 · 243 citations

Effect of <i>CYP2C19</i> *2 and *17 mutations on pharmacodynamics and kinetics of proton pump inhibitors in Caucasians

Nicole Hunfeld, Ron A. A. Mathôt, Daan J. Touw et al. · British Journal of Clinical Pharmacology · 2008 · 85 citations · Full text

Genetic and clinical features of patients with cystic fibrosis diagnosed after the age of 16 years.

K. H. Gan, W. P. Geus, W. Bakker et al. · Thorax · 1995 · 84 citations · Full text

Gastro-oesophageal Reflux Disease in the Netherlands. Results of a Multicentre pH Study

A. J. P. M. Smout, W. P. Geus, P. G. H. Mulder et al. · Scandinavian Journal of Gastroenterology · 1996 · 60 citations

Esophagus, Multicentre Ph Study, Gastroenterology +9

A comparison of the acid‐inhibitory effects of esomeprazole and pantoprazole in relation to pharmacokinetics and CYP2C19 polymorphism

Nicole Hunfeld, Daan J. Touw, Ron A. A. Mathôt et al. · Alimentary Pharmacology & Therapeutics · 2009 · 46 citations